Some reports showed that MEIS1 can be identified as a negative regulator in some cancers, such as non-small-cell lung cancer, prostate cancer, and esophageal squamous cell carcinoma [14–16]. This evidence concerns the gene MEIS1 and Familial prostate cancer.